Description |
Isofraxidin, a coumarin component from Acanthopanax senticosus, inhibits MMP-7 expression and cell invasion of human hepatoma cells. Isofraxidin inhibits the phosphorylation of ERK1/2 in hepatoma cells[1]. Isofraxidin attenuates the expression of iNOS and COX-2, Isofraxidinalso inhibits TLR4/myeloid differentiation protein-2 (MD-2) complex formation[2].
|
Target |
COX-2
TLR4
MMP-7
|
In Vitro |
Isofraxidin inhibits expression of MMP-7 and in vitro cell invasion at a non-toxic level through inhibiting ERK1/2 phosphorylation in hepatoma cell lines[1]. Isofraxidin competitively inhibits TLR4/MD-2 complex formation, and thus TLR4/NF-κB signalling cascades.Isofraxidin has potential in the treatment of Osteoarthritis (OA)[2].
|
Density | 1.4±0.1 g/cm3 |
Boiling Point | 452.1±45.0 °C at 760 mmHg |
Flash Point | 183.2±22.2 °C |
Exact Mass | 222.052826 |
PSA | 68.90000 |
LogP | 1.31 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Storage condition | ?20°C |